Tanei Ryoji, Hasegawa Yasuko
Department of Dermatology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi, Tokyo, Japan.
Department of Geriatric Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi, Tokyo, Japan.
Geriatr Gerontol Int. 2016 Mar;16 Suppl 1:75-86. doi: 10.1111/ggi.12771.
Atopic dermatitis (AD) in older adults represents a newly defined subgroup of AD. The prevalence of elderly AD is approximately 1-3% among elderly populations in industrialized countries. Elderly patients with AD show some common clinical characteristics, such as a male predominance, a lower incidence of lichenified eczema at the elbow and knee folds, and particular patterns of onset and clinical course. Both immunoglobulin (Ig)E-allergic and non-IgE-allergic types are observed in elderly AD. Elderly patients with IgE-allergic AD show high rates of positivity for specific IgE antibodies against house dust mites, associations with IgE allergic and asthmatic complications, histopathological features with a predominance of IgE-mediated allergic inflammation in the lesional skin, and a significantly lower incidence of malignancy as compared with control subjects. The etiology of elderly AD might be associated with immunosenescence, age-related changes to the sex hormone milieu, age-related barrier dysfunctions in the skin and gut, functional disturbance of sweat production, and environmental stimuli in the lifestyle of elderly individuals. Powerful anti-inflammatory treatments, such as oral corticosteroids, might be required together with standard treatments to manage moderate to severe cases of elderly AD. Finally, most elderly patients with AD reach the end of life with this disease, which should now be considered a lifelong allergic disease.
老年人特应性皮炎(AD)是AD新定义的一个亚组。在工业化国家的老年人群中,老年AD的患病率约为1%-3%。老年AD患者表现出一些共同的临床特征,如男性居多、肘膝褶皱处苔藓化湿疹发病率较低以及特定的发病模式和临床病程。老年AD患者中观察到免疫球蛋白(Ig)E过敏型和非IgE过敏型。IgE过敏型老年AD患者对屋尘螨的特异性IgE抗体阳性率较高,与IgE过敏和哮喘并发症相关,皮损组织病理学特征以IgE介导的过敏性炎症为主,与对照组相比恶性肿瘤发病率显著较低。老年AD的病因可能与免疫衰老、性激素环境的年龄相关变化、皮肤和肠道的年龄相关屏障功能障碍、汗液分泌功能紊乱以及老年人生活方式中的环境刺激有关。对于中度至重度老年AD病例,可能需要联合使用强效抗炎治疗(如口服糖皮质激素)和标准治疗。最后,大多数老年AD患者会带着这种疾病走到生命尽头,现在应将其视为一种终身过敏性疾病。